GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jilin Province Huinan Changlong Bio-pharmacy Co Ltd (HKSE:08049) » Definitions » Receivables Turnover

Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) Receivables Turnover : 0.93 (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Jilin Province Huinan Changlong Bio-pharmacy Co Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Jilin Province Huinan Changlong Bio-pharmacy Co's Revenue for the three months ended in Dec. 2023 was HK$272.0 Mil. Jilin Province Huinan Changlong Bio-pharmacy Co's average Accounts Receivable for the three months ended in Dec. 2023 was HK$293.5 Mil. Hence, Jilin Province Huinan Changlong Bio-pharmacy Co's Receivables Turnover for the three months ended in Dec. 2023 was 0.93.


Jilin Province Huinan Changlong Bio-pharmacy Co Receivables Turnover Historical Data

The historical data trend for Jilin Province Huinan Changlong Bio-pharmacy Co's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jilin Province Huinan Changlong Bio-pharmacy Co Receivables Turnover Chart

Jilin Province Huinan Changlong Bio-pharmacy Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.51 2.76 3.28 3.14 3.02

Jilin Province Huinan Changlong Bio-pharmacy Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.88 0.51 0.92 0.70 0.93

Competitive Comparison of Jilin Province Huinan Changlong Bio-pharmacy Co's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Jilin Province Huinan Changlong Bio-pharmacy Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jilin Province Huinan Changlong Bio-pharmacy Co's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jilin Province Huinan Changlong Bio-pharmacy Co's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Jilin Province Huinan Changlong Bio-pharmacy Co's Receivables Turnover falls into.



Jilin Province Huinan Changlong Bio-pharmacy Co Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Jilin Province Huinan Changlong Bio-pharmacy Co's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Receivables Turnover (A: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (A: Dec. 2023 ) / ((Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count )
=920.464 / ((315.814 + 293.49) / 2 )
=920.464 / 304.652
=3.02

Jilin Province Huinan Changlong Bio-pharmacy Co's Receivables Turnover for the quarter that ended in Dec. 2023 is calculated as

Receivables Turnover (Q: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (Q: Dec. 2023 ) / ((Accounts Receivable (Q: Sep. 2023 ) + Accounts Receivable (Q: Dec. 2023 )) / count )
=272.029 / ((0 + 293.49) / 1 )
=272.029 / 293.49
=0.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jilin Province Huinan Changlong Bio-pharmacy Co  (HKSE:08049) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Jilin Province Huinan Changlong Bio-pharmacy Co Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Jilin Province Huinan Changlong Bio-pharmacy Co's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) Business Description

Traded in Other Exchanges
Address
625 & 639 Nathan Road, Room 1101-2, 11th Floor, Office Tower Two, Grand Plaza, Mong kok, Kowloon, Hong Kong, HKG
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is a pharmaceutical company. It is engaged in the manufacturing and distribution of Chinese medicines and pharmaceutical products. The company sells medicines under the brand names: Changlong and Qing Tong. The group has only one business segment which is the manufacture and distribution of Chinese medicines. It derives revenue primarily from operations in the PRC.

Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) Headlines

No Headlines